Company | Name | Exchange | Sector | Industry | Market Cap | P/E Ratio | PEG Ratio | Last Trade Price | Day Change (%) | Fair Value | Fair Value Upside | Fair Value Label | Analyst Price Target | Analyst Target Upside | Overall Health |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Eli Lilly | Vienna | Healthcare | Pharmaceuticals | €595.94B | 62.7x | 0.73 | €664.10 | -2.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Johnson & Johnson | Vienna | Healthcare | Pharmaceuticals | €338.81B | 17.5x | -0.44 | €141.36 | 0.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Abbvie | Vienna | Healthcare | Pharmaceuticals | €287.57B | 80.6x | -2.67 | €163.60 | -0.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Novo Nordisk AS | Vienna | Healthcare | Pharmaceuticals | €246.43B | 17.6x | 0.99 | €55.58 | -2.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
AstraZeneca DRC | Vienna | Healthcare | Pharmaceuticals | €184.10B | 27.6x | 1.21 | €60 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Merck & Co | Vienna | Healthcare | Pharmaceuticals | €172.71B | 11.6x | 0.02 | €69.40 | -2.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Amgen | Vienna | Healthcare | Pharmaceuticals | €136.34B | 26.8x | 0.48 | €255.05 | -0.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Pfizer | Vienna | Healthcare | Pharmaceuticals | €119.67B | 17.6x | 0.01 | €21.07 | -1.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Gilead Sciences | Vienna | Healthcare | Pharmaceuticals | €115.80B | 22.6x | 0.02 | €93.88 | -0.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Vertex Pharma | Vienna | Healthcare | Pharmaceuticals | €101.57B | -119.6x | 0.96 | €398.85 | -1.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Sanofi | Vienna | Healthcare | Pharmaceuticals | €101.26B | 16.7x | 0.41 | €83.41 | 0.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Bristol Myers Squibb | Vienna | Healthcare | Pharmaceuticals | €82.91B | 17.8x | 0.09 | €41 | -1.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Zoetis | Vienna | Healthcare | Pharmaceuticals | €56.91B | 26.5x | 3.63 | €127.22 | -1.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Regeneron Pharma | Vienna | Healthcare | Pharmaceuticals | €49.31B | 13x | 0.78 | €468.90 | -1.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Merck KGaA | Vienna | Healthcare | Pharmaceuticals | €48.09B | 17.1x | 4.96 | €110.95 | -0.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Takeda Pharmaceutical | Vienna | Healthcare | Pharmaceuticals | €39.62B | 63.5x | -2.44 | €25.19 | -1.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Ucb SA | Vienna | Healthcare | Pharmaceuticals | €33.23B | 31.1x | 0.15 | €174.10 | 0.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Bayer | Vienna | Healthcare | Pharmaceuticals | €27.18B | -8.4x | €27.73 | -0.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | |||
Teva Pharmaceutical Industries DRC | Vienna | Healthcare | Pharmaceuticals | €15.85B | -14.3x | 0.09 | €13.90 | -0.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Biogen Inc | Vienna | Healthcare | Pharmaceuticals | €15.75B | 12.4x | 0.48 | €108.65 | -2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Recordati Industria Chimica e | Vienna | Healthcare | Pharmaceuticals | €10.81B | 25.9x | 3.44 | €52.65 | 0.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Moderna | Vienna | Healthcare | Pharmaceuticals | €10.40B | -3.6x | -0.08 | €27.24 | -1.6% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Biomarin Pharma | Vienna | Healthcare | Pharmaceuticals | €9.45B | 21.6x | 0.14 | €50.12 | -2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Viatris | Vienna | Healthcare | Pharmaceuticals | €8.97B | -2.8x | 0 | €7.69 | -3.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Ipsen | Vienna | Healthcare | Pharmaceuticals | €8.80B | 24.8x | -0.53 | €106.80 | 0.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Grifols | Vienna | Healthcare | Pharmaceuticals | €7.30B | 37x | €12.02 | -2.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | |||
H Lundbeck AS | Vienna | Healthcare | Pharmaceuticals | €4.39B | 11.6x | 0.28 | €4.53 | -1.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
H Lundbeck AS | Vienna | Healthcare | Pharmaceuticals | €4.39B | 11.6x | 0.28 | €4 | -1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Laboratorios Farmaceuticos ROVI | Vienna | Healthcare | Pharmaceuticals | €2.70B | 19.3x | €53.05 | -0.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | |||
Almirall | Vienna | Healthcare | Pharmaceuticals | €2.30B | 94x | €10.74 | 0.6% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | |||
Bavarian Nordic AS | Vienna | Healthcare | Pharmaceuticals | €1.92B | 11.2x | 0.35 | €24.73 | 0.9% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Dermapharm Holding SE | Vienna | Healthcare | Pharmaceuticals | €1.85B | 17.8x | 0.22 | €34.20 | -1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Pharma Mar | Vienna | Healthcare | Pharmaceuticals | €1.39B | 53.3x | €80.75 | -0.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | |||
Cosmo Pharmaceuticals NV | Vienna | Healthcare | Pharmaceuticals | €1.05B | 8.1x | 0.01 | €66 | -0.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Tilray Brands | Vienna | Healthcare | Pharmaceuticals | €540.94M | -0.6x | 0.01 | €0.54 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Medios | Vienna | Healthcare | Pharmaceuticals | €323.41M | 21.4x | -0.97 | €12.64 | 0.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Pentixapharm Holding | Vienna | Healthcare | Pharmaceuticals | €48.33M | -4.2x | €2.01 | 0.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | |||
Marinomed Biotech AG | Vienna | Healthcare | Pharmaceuticals | €35.48M | -1.4x | 0.02 | €19.95 | -0.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ |